Mallory guides clients through personalized GLP-1 treatment plans with a focus on education and informed decision-making
Trademark Information: Setria is a registered trademark of Kyowa Hakko Bio Co., Ltd
The decision depends on individual recovery factors including return of normal bowel function, ability to tolerate oral intake without significant nausea, stable hydration status, and clearance from your surgical team and prescribing physician
Your provider may recommend slower dose escalation, temporary dose reduction, hydration support, or evaluation for unrelated infection
Setting Realistic Expectations No supplementwhether prescription or over-the-counterproduces significant sustained weight loss without behavioral changes
CagriSema (cagrilintide plus semaglutide) CagriSema takes a different approach to exceeding tirzepatide results